The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vasopressin
Vasopressin · VASOPRESSIN 20 [USP'U]/mL · Injection, Solution · Intravenous · Civica, Inc.
NDC 72572-0860-25 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$456.25
Reported to Texas DSHS · 2026 annual filing · Civica, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 UNIT
$0.834
HCPCS J2599 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- American Regent, Inc.United Stateslabel · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA212593
- TE code
- —
- Approval date
- Aug 3, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vasopressin (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Regent, Inc. | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 3, 2026 |
| Civica, Inc. | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Aug 31, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vasopressin — NDC 72572-0860-25," retrieved September 3, 2026, https://drugdashboards.com/drug/72572086025.
Free to cite with attribution — see how the data is put together.